3D-Printed Device Detects Biomarkers of Preterm Birth
By LabMedica International staff writers Posted on 06 Jun 2019 |
Image: A diagram of the 3D-printed microchip electrophoresis device that can sensitively detect three serum biomarkers of preterm birth (Photo courtesy of Brigham Young University).
Preterm birth (PTB), defined as birth before the 37th week of gestation, is the leading complication of pregnancy and it affects about 1 in 10 pregnancies worldwide. Preterm infants can suffer complications such as neurological, respiratory and cardiac problems and, in some cases, even death.
Scientists have previously identified biomarker peptides and proteins in maternal serum that can fairly accurately predict PTB at 28 weeks of gestation. However, existing methods for detecting the biomarkers are laborious or not very sensitive. Now scientists have created a 3D-printed microchip electrophoresis device that can sensitively detect three serum biomarkers of PTB.
Biochemists at Brigham Young University (Provo, UT, USA) demonstrated for the first time the creation of microchip electrophoresis devices with ∼50 μm cross-sectional dimensions by stereolithographic 3D printing and their application in the analysis of medically significant biomarkers related to risk for preterm birth (PTB).
The team printed their device onto a glass slide using a 3D printer with a custom resin as the ink. To achieve the best separation of three peptide biomarkers by electrophoresis, they optimized the device design, as well as parameters such as applied voltages and buffer identity and composition. The 3D-printed microchip could detect the three PTB biomarkers in the picomolar to low nanomolar range. They determined that device current was linear with applied potential up to 800 V (620 V/cm). The group optimized device and separation conditions using fluorescently labeled amino acids as a model system and compared the performance in their 3D printed microfluidic devices to that in other device materials commonly used for microchip electrophoresis analysis.
The authors concluded that they had demonstrated for the first time microchip electrophoresis in a 3D printed device of three PTB biomarkers, including peptides and a protein, with suitable separation characteristics. Limits of detection for microchip electrophoresis in 3D printed microfluidic devices were also determined for PTB biomarkers to be in the high picomolar to low nanomolar range. The study was published on May 6, 2019, in the journal Analytical Chemistry.
Related Links:
Brigham Young University
Scientists have previously identified biomarker peptides and proteins in maternal serum that can fairly accurately predict PTB at 28 weeks of gestation. However, existing methods for detecting the biomarkers are laborious or not very sensitive. Now scientists have created a 3D-printed microchip electrophoresis device that can sensitively detect three serum biomarkers of PTB.
Biochemists at Brigham Young University (Provo, UT, USA) demonstrated for the first time the creation of microchip electrophoresis devices with ∼50 μm cross-sectional dimensions by stereolithographic 3D printing and their application in the analysis of medically significant biomarkers related to risk for preterm birth (PTB).
The team printed their device onto a glass slide using a 3D printer with a custom resin as the ink. To achieve the best separation of three peptide biomarkers by electrophoresis, they optimized the device design, as well as parameters such as applied voltages and buffer identity and composition. The 3D-printed microchip could detect the three PTB biomarkers in the picomolar to low nanomolar range. They determined that device current was linear with applied potential up to 800 V (620 V/cm). The group optimized device and separation conditions using fluorescently labeled amino acids as a model system and compared the performance in their 3D printed microfluidic devices to that in other device materials commonly used for microchip electrophoresis analysis.
The authors concluded that they had demonstrated for the first time microchip electrophoresis in a 3D printed device of three PTB biomarkers, including peptides and a protein, with suitable separation characteristics. Limits of detection for microchip electrophoresis in 3D printed microfluidic devices were also determined for PTB biomarkers to be in the high picomolar to low nanomolar range. The study was published on May 6, 2019, in the journal Analytical Chemistry.
Related Links:
Brigham Young University
Latest Clinical Chem. News
- 3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models
- POC Biomedical Test Spins Water Droplet Using Sound Waves for Cancer Detection
- Highly Reliable Cell-Based Assay Enables Accurate Diagnosis of Endocrine Diseases
- New Blood Testing Method Detects Potent Opioids in Under Three Minutes
- Wireless Hepatitis B Test Kit Completes Screening and Data Collection in One Step
- Pain-Free, Low-Cost, Sensitive, Radiation-Free Device Detects Breast Cancer in Urine
- Spit Test Detects Breast Cancer in Five Seconds
- Electrochemical Sensors with Next-Generation Coating Advances Precision Diagnostics at POC
- First-Of-Its-Kind Handheld Device Accurately Detects Fentanyl in Urine within Seconds
- New Fluorescent Sensor Array Lights up Alzheimer’s-Related Proteins for Earlier Detection
- Automated Mass Spectrometry-Based Clinical Analyzer Could Transform Lab Testing
- Highly Sensitive pH Sensor to Aid Detection of Cancers and Vector-Borne Viruses
- Non-Invasive Sensor Monitors Changes in Saliva Compositions to Rapidly Diagnose Diabetes
- Breakthrough Immunoassays to Aid in Risk Assessment of Preeclampsia
- Urine Test for Monitoring Changes in Kidney Health Markers Can Predict New-Onset Heart Failure
- AACC Releases Comprehensive Diabetes Testing Guidelines